Tag: anti-HER2 monoclonal antibody

Lessons from real-world implementation of lung cancer screening

Trastuzumab deruxtecan showed therapeutic efficacy in HER2-mutant non-small cell lung cancer

byBoaz Wongand1 others

January 20, 2022

1. Patients with refractory HER2-mutant non-small cell lung cancer (NSCLC) show clinical response to trastuzumab deruxtecan. 2. Safety profiles were ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Efficacy of standard care versus acoustic therapy on acute tinnitus in idiopathic sudden sensorineural hearing loss: a randomized controlled trial
Opioid overdose associated with concomitant use of hydrocodone and selective serotonin reuptake inhibitors
Analysis of arrhythmia and its risk factors in patients with COVID-19

No Result

View All Result